Article title: MiR-152 influences osteoporosis through regulation of osteoblast differentiation by targeting RICTOR
Authors: L. Feng, B. Xia, B.-F. Tian, & G.-B. Lu
Journal: Pharmaceutical Biology
Bibliometrics: Volume 57, Number 1, pages 586–594
DOI: http://dx.doi.org/10.1080/13880209.2019.1657153
The authors have found out that Figures 5 and 6, and the sentence starting as “However, miR-152 inhibitor + siRICTOR group showed no significant difference…” coming under the sub-section “Expression of miR-152, RICTOR and downstream proteins in osteoblasts” of the Results section have some errors that need to be rectified.
The revised Figure 5 would appear as below:
The revised Figure 6 would appear as below:
In the sub-section “Expression of miR-152, RICTOR and downstream proteins in osteoblasts” of the Results section, the sentence “However, miR-152 inhibitor + siRICTOR group showed no significant difference in miR-152 from miR-152 inhibitor group, with significantly increased levels of RICTOR and p-Akt (s473)/Akt (all p < 0.05)” should read, “However, miR-152 inhibitor + siRICTOR group showed no significant difference in miR-152 from miR-152 inhibitor group, with significantly decreased levels of RICTOR and p-Akt (s473)/Akt (all p < 0.05).”